Syed Muhammad Dildar

Betrixaban for first-line venous thromboembolism prevention in acute medically ill patients with risk factors for venous thromboembolism

T. Nafee, C. Gibson, M. Kerneis, 2018, Expert review of cardiovascular therapy.